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Introduction
Many disorders of the central nervous system
(CNS) are accompanied by increased protein con-
centration in the cerebrospinal fluid (CSF), which can
be attributable to an altered permeability of the blood-
brain barrier, to intrathecal synthesis of immunoglo-
bulins, or to the combination of both (1). Examina-
tion of CSF total protein and specific proteins is used
chiefly to detect increased permeability of the blood-
brain barrier to plasma proteins or to detect increa-
sed intrathecal production of immunoglobulins. The
degree of permeability of the blood-brain barrier can
be evaluated by immunochemical measurements of
albumin in CSF and in serum specimens obtained at
the same time. Albumin is a particulary suitable pro-
tein because it is neither synthesized nor metabolized
intrathecally. Demonstration of increased intrathecal
immunoglobulin synthesis resulting from infiltration
of IgG-producing lymphocytes inside brain and spinal
cord is a specific indication for the presence of infla-
mmation in the CNS. Albumin can cross the blood-
brain barrier, but in contrast to IgG, cannot be pro-
duced in the CNS itself (2).
Several disorders of the CNS such as bacterial
meningitis, multiple sclerosis and other CNS inflam-
matory diseases, are associated with an increase in
protein concentration in  CSF (3, 4). In this context,
the examination of the CSF includes quantitative
measurements of immunoglobulin and albumin con-
centrations in comparison with the serum. The pur-
pose of this work was to establish the degree of blood
brain barrier damage in inflammatory and noninflam-
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Summary: The differential diagnosis between inflammatory and noninflammatory diseases of CNS inclu-
des CSF quantitative measurements of immunoglobulin and albumin concentrations and their comparison to
the serum. For that purpose we estimated the concentrations of albumin and immunoglobulin G both in CSF
and serum of patients with inflammatory and noninflammatory  diseases of CNS. Parallely, these parameters
were determined in the control group composed of patients having the values of investigated parameters  with-
in reference ranges. The obtained data were statistically evaluated by nonparametric Mann-Whitney test. The
values of calculated CSF/albumin ratio have shown significant differences between the both patient groups and
the control one (p < 0.001). It proves that in each examined group the blood brain barrier is damaged. For the
assessment of intrathecal IgG synthesis we have calculated both IgG/albumin index and Schuller index. The
comparison of the values obtained for patients with noninflammatory diseases to the control one, revealed no
statistically significant differences  (p > 0.05). On the contrary, significant difference have been observed bet-
ween the group with inflammatory diseases and the control (p < 0.05), proving the existence of IgG intrathe-
cal synthesis. Values of both indexes were much higher in patients with inflammatory than noninflamatory dise-
ases, meaning that they can be used in differential diagnosis.
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matory diseases, intrathecal synthesis of IgG and  to
use the data in differential diagnosis between the two
types of CNS diseases. 
Materials and Methods
The investigations were performed on patients
with inflammatory and noninflammatory disease of
CNS. Patients with inflammatory disease (n = 20)
had clinically confirmed diagnosis of tuberculosis
meningitis. In the group with noninflamatory disease
(n = 20) were patients with diagnosis of poliradicu-
loneuritis, vascular disorders and brain carcinoma,
while tuberculoses meningitis was excluded. Patients
who had normal concentrations of total proteins,
albumin and globulins in both serum and CSF were
used as the control.
CSF and blood were obtained by lumbar punc-
ture (L5-L6) and venipuncture, respectively. Blood
samples were drawn without anticoagulant and cen-
trifuged (3000 g for 10 min at 4 °C), and serum was
harvested. All samples were stored at –20 °C before
being processed. Albumin and IgG were measured in
serum and unconcentrated CSF by immunoturbidi-
metry using Turbitimer (Dade-Behring) with calibra-
tors and internal controls provided by Dade-Behring
and according to manufacturer’s recommendations.
As a mirror of blood-CSF barrier status, the
CSF/serum albumin ratio was calculated; its thresh-
old of positivity varied between 6 × 10–3 and 8 ×
10–3 with the age of patients. To detect intrathecal
synthesis of IgG (ISI), we calculated the IgG/albumin
index (5) and the Schuller index (6). The IgG/albumin
index was calculated by the following formula: 
IgG/Albumin index = (IgGCSF/IgGserum) / (albuminCSF/albu-
minserum)
and was positive above 0.65. The Schuller index was
defined by the following formula:
ISI (mg/L) = IgGCSF – {30 + [(albuminCSF – 240)/60] ×
IgGserum}
Intrathecal synthesis of IgG is suspected when
the result is > 0 mg/L.
Results and Discussion
The data we have obtained for CSF albumin
and immunoglobulin G are presented in Table I.
The CSF albumin concentration was significan-
tly increased  both in patients with inflammatory and
noninflamatory disease, which was already confirmed
in the literature (7). Significant difference was found
between each patient group and the control one (p <
0.001), but not between the patient groups themself
(p > 0.05).
The concentrations of IgG in CSF were increa-
sed in both groups of patients, and significant diffe-
rences was found in comparison to the control (p <
0.001),  which is in agreement with literature data (8).
The differences in IgG concentration were also found
between patients with inflamatory and noninflamato-
ry CNS disease (p < 0.05).
For the evaluation of the  blood-brain barrier da-
mage, we have calculated the albumin index. The re-
sults are presented in Table II. 
Compared to the control group there was a sig-
nificant  increament in patients both with noninflam-
atory (p < 0.001) and inflamatory disease (p < 0.001).
No significant differences were found for albumin
index  between the two patient groups  (p > 0.05).
The preferred method for the measurement of
blood-CSF barrier dysfunction is the analysis of albu-
min quotient and its evaluation with regard to the
agerelated reference range (9). The analysis of total
protein is still frequently used for evaluation of barrier
dysfunction because it does offer some clinical value
in spite of its broad reference range, i.e., lower sensi-
tivity, and specificity than albumin quotient. Due to
systematic inflammatory diseases with high total pro-
tein concentrations in blood, high total concentra-
tions in CSF are subsrequently observed. This could
lead to falce positive interpretation but could be
avoided by using the albumin quotient (10).
The immunoglobulin index was calculated in
order to prove possible intrathecal synthesis of IgG. In
patients with inlamatory CNS disease, the index was
increased, which was not the case with noninflama-
tory diseases (Table III).
Table I   Concentrations of CSF albumin and immunoglobulin G in the control group (I) 
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This finding confirm the existance of IgG syn-
thesis as a response to the infectious agens (11). By
comparisson of IgG index between the investigated
groups, statistically significant differences was found
(p < 0.001).
The determination of CSF/serum quotients is
regarded as a suitable evaluation and interpretation
method for the detection of intrathecal IgG, IgA or
IgM synthesis. As reviewed recently, the frequently
used IgG Index or IgG Synthesis rate give up to 90%
falce-positive values for high albumin quotients (blood-
CSF barrier dysfunction) compared to the gold stan-
dard, which is the detection of oligoclonal bands on
isoelectric focusing (IEF). Regarding quantitative ana-
lyses of intrathecal immunoglobulin synthesis, there
is an agreement to refer to hyperbolic discrimination
line, expressed in either a numerical or graphical for-
mat (12, 13). This is often facilitated by use of PC-ba-
sed software for evaluation of CSF data profiles, and
thus knowledge-based interpretation programs sup-
port routine CSF analysis (12, 14). 
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Kratak sadr`aj: Diferencijalna dijagnoza inflamatornih i neinflamatornih oboljenja CNS-a, obuhvata kvan-
titativno odre|ivanje koncentracija imunoglobulina i albumina, kao i njihovo pore|enje sa serumom. Koncen-
tracije albumina i imunoglobulina G odre|ene su u cerebrospinalnoj te~nosti (CST) u serumu pacijenata sa
inflamatornim i neinflamatornim oboljenjima CNS-a. Ovi parametri odre|eni su i u kontrolnoj grupi, sa~injenoj
od pacijenata kod kojih su ispitivani parametri bili u granicama referentnih vrednosti. Dobijeni rezultati statisti{ki
su obra|eni neparametarskim Mann-Whitney testom. Izra~unate vrednosti CSF/albumin pokazale su statisti~ki
zna~ajne razlike izme|u obe grupe pacijenata i kontrolne grupe (p< 0,001). Ovo dokazuje da je kod obe grupe
pacijenata krvno mo`dana barijera o{te}ena. Za procenu intratekalne sinteze IgG izra~unati su Ig/albumin
indeks i Schuller-ov index. Pore|enjem vrednosti za pacijente sa nezapaljenskim oboljenjima i kontrolne grupe
nisu na|ene zna~ajne razlike (p > 0,05). Suprotno, statisti~ki zna~ajne razlike uo~ene su izme|u grupe sa infla-
matornim oboljenjima i kontrolne grupe (p < 0,05), {to ukazuje na postojanje intratekalne sinteze IgG-a. Vred-
nosti izra~unatih indeksa za zapaljenske procese bile su zna~ajno vi{e u odnosu na nezapaljenska oboljenja (p
< 0,05), {to se mo`e iskoristiti za diferencijalnu dijagnozu ovih oboljenja.
Klju~ne re~i: cerebrospinalna te~nost, albumin, imunoglobulin G, odnos CSF/albumin, IgG/albumin
indeks
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